Send Message
Home News

company news about Monkeypox outbreak poses ‘moderate risk’ to global public health, WHO says

China Hangzhou AllTest Biotech CO.,LTD certification
Customer Reviews
We recently started selling your HCG tests via our Australian partner and have been very impressed with the quality and consistency of the tests. They seem to be superior to our current manufacturer and we also know that you are far more reliable in terms of production times and communication.

—— One customer from Europe

We would like to explore the possibility of switching our HCG tests over to you. We have been reluctant in the past to move everything over to you as it makes us very reliant on you. However, we have always found you to be by far the most reliable of all our Chinese manufacturers and so we feel comfortable strengthening our partnership further

—— One customer from Europe

I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

I'm Online Chat Now
Company News
Monkeypox outbreak poses ‘moderate risk’ to global public health, WHO says
Latest company news about Monkeypox outbreak poses ‘moderate risk’ to global public health, WHO says

The ongoing monkeypox outbreak currently poses a moderate risk to global public health, the World Health Organization said Sunday in a statement that nevertheless raised the specter of the virus becoming entrenched as a pathogen that spreads from person to person.


The WHO said that 23 countries have reported a total of 257 confirmed cases and roughly 120 suspected cases under investigation as of May 26 — a rapid accumulation of cases in an unprecedented outbreak that was first detected earlier this month. To date most of the cases have been diagnosed in Europe and North America. The United States had detected 12 cases as of Friday.

“Currently, the overall public health risk at [a] global level is assessed as moderate considering this is the first time that monkeypox cases and clusters are reported concurrently in widely disparate WHO geographical areas,” the global health agency said.


“The public health risk could become high if this virus exploits the opportunity to establish itself as a human pathogen and spreads to groups at higher risk of severe disease such as young children and immunosuppressed persons,’’ the statement said, noting that since smallpox vaccination ceased more than 40 years ago, an ever-growing portion of the global population is vulnerable to the monkeypox virus.


Monkeypox is an orthopoxvirus, a family that includes the now eradicated smallpox virus; vaccines and drugs developed to ward off or treat smallpox are expected to offer some protection against monkeypox. Monkeypox triggers milder illness than smallpox did — the latter was fatal in about 30% of cases. The fatality rate for monkeypox is estimated to be between 1% and 10%, with the viruses responsible for the current outbreak, from the West African clade, associated with a fatality rate at the low end of that spectrum.


The majority of the cases in this outbreak have been detected in men who have sex with men. And while the WHO is asking countries to look for missed cases when they do contact tracing, most of the cases being reported are active, meaning they currently have symptoms, Maria Van Kerkhove, who leads the emerging diseases and zoonoses unit in the WHO’s Health Emergencies Program, told STAT.

Pub Time : 2022-05-30 09:30:13 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: 86-13989889852

Send your inquiry directly to us (0 / 3000)